Stenocare A/S (CPH:STENO)

Stenocare Statistics

Total Valuation

Stenocare has a market cap or net worth of DKK 49.27 million. The enterprise value is 47.24 million.

Market Cap	49.27M
Enterprise Value	47.24M

Important Dates

The last earnings date was Thursday, August 21, 2025.

Earnings Date	Aug 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Stenocare has 38.20 million shares outstanding. The number of shares has increased by 50.64% in one year.

Current Share Class	38.20M
Shares Outstanding	38.20M
Shares Change (YoY)	+50.64%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	29.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.39
PB Ratio	21.55
P/TBV Ratio	21.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.62
EV / Sales	16.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.64, with a Debt / Equity ratio of 1.24.

Current Ratio	1.64
Quick Ratio	1.47
Debt / Equity	1.24
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-28.08

Financial Efficiency

Return on equity (ROE) is -281.87% and return on invested capital (ROIC) is -92.09%.

Return on Equity (ROE)	-281.87%
Return on Assets (ROA)	-79.52%
Return on Invested Capital (ROIC)	-92.09%
Return on Capital Employed (ROCE)	-661.01%
Revenue Per Employee	354,101
Profits Per Employee	-3.65M
Employee Count	8
Asset Turnover	0.16
Inventory Turnover	47.11

Taxes

In the past 12 months, Stenocare has paid 391,671 in taxes.

Income Tax	391,671
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.76% in the last 52 weeks. The beta is 0.22, so Stenocare's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	-50.76%
50-Day Moving Average	0.80
200-Day Moving Average	0.71
Relative Strength Index (RSI)	62.87
Average Volume (20 Days)	681,488

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Stenocare had revenue of DKK 2.83 million and -29.17 million in losses. Loss per share was -1.15.

Revenue	2.83M
Gross Profit	-16.70M
Operating Income	-22.52M
Pretax Income	-28.78M
Net Income	-29.17M
EBITDA	-20.79M
EBIT	-22.52M
Loss Per Share	-1.15

Balance Sheet

The company has 4.87 million in cash and 2.83 million in debt, giving a net cash position of 2.04 million or 0.05 per share.

Cash & Cash Equivalents	4.87M
Total Debt	2.83M
Net Cash	2.04M
Net Cash Per Share	0.05
Equity (Book Value)	2.29M
Book Value Per Share	0.06
Working Capital	3.33M

Cash Flow

Operating Cash Flow	-5.37M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-794.90%
Pretax Margin	-1,016.07%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Stenocare does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-50.64%
Shareholder Yield	n/a
Earnings Yield	-59.21%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Stenocare has an Altman Z-Score of -5.01 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.01
Piotroski F-Score	3